Eli Lilly and (LLY)
Eli Lilly and Statistics
Share Statistics
Eli Lilly and has 949.32M shares outstanding. The number of shares has increased by -0.15% in one year.
| Shares Outstanding | 949.32M |
| Shares Change (YoY) | -0.15% |
| Shares Change (QoQ) | -0.12% |
| Owned by Institutions (%) | 86.36% |
| Shares Floating | 850.40M |
| Failed to Deliver (FTD) Shares | 563 |
| FTD / Avg. Volume | 0.02% |
Short Selling Information
The latest short interest is 7.22M, so 0.76% of the outstanding shares have been sold short.
| Short Interest | 7.22M |
| Short % of Shares Out | 0.76% |
| Short % of Float | 0.85% |
| Short Ratio (days to cover) | 1.91 |
Valuation Ratios
The PE ratio is 65.93 and the forward PE ratio is 35.77. Eli Lilly and's PEG ratio is 0.65.
| PE Ratio | 65.93 |
| Forward PE | 35.77 |
| PS Ratio | 15.5 |
| Forward PS | 8.5 |
| PB Ratio | 48.75 |
| P/FCF Ratio | 0 |
| PEG Ratio | 0.65 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Eli Lilly and.
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0, with a Debt / Equity ratio of 0.
| Current Ratio | 0 |
| Quick Ratio | 0 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0 |
| Cash Flow / Debt | 0 |
| Interest Coverage | 21.31 |
Financial Efficiency
Return on equity (ROE) is 0.74% and return on capital (ROIC) is 75.22%.
| Return on Equity (ROE) | 0.74% |
| Return on Assets (ROA) | 0.13% |
| Return on Capital (ROIC) | 75.22% |
| Revenue Per Employee | 1.05M |
| Profits Per Employee | 246.28K |
| Employee Count | 43.00K |
| Asset Turnover | 0.57 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 2.09B |
| Effective Tax Rate | 0.16 |
Stock Price Statistics
The stock price has increased by 17.08% in the last 52 weeks. The beta is 0.41, so Eli Lilly and's price volatility has been higher than the market average.
| Beta | 0.41 |
| 52-Week Price Change | 17.08% |
| 50-Day Moving Average | 800.36 |
| 200-Day Moving Average | 847.08 |
| Relative Strength Index (RSI) | 62.14 |
| Average Volume (20 Days) | 3.62M |
Income Statement
In the last 12 months, Eli Lilly and had revenue of 45.04B and earned 10.59B in profits. Earnings per share was 11.71.
| Revenue | 45.04B |
| Gross Profit | 36.62B |
| Operating Income | 12.90B |
| Net Income | 10.59B |
| EBITDA | 18.75B |
| EBIT | 12.90B |
| Earnings Per Share (EPS) | 11.71 |
Balance Sheet
The company has 3.27B in cash and 0 in debt, giving a net cash position of 3.27B.
| Cash & Cash Equivalents | 3.27B |
| Total Debt | 0 |
| Net Cash | 3.27B |
| Retained Earnings | 0 |
| Total Assets | 75.61B |
| Working Capital | 6.74B |
Cash Flow
In the last 12 months, operating cash flow was 0 and capital expenditures 0, giving a free cash flow of 0.
| Operating Cash Flow | 0 |
| Capital Expenditures | 0 |
| Free Cash Flow | 0 |
| FCF Per Share | 0 |
Margins
Gross margin is 81.31%, with operating and profit margins of 28.64% and 23.51%.
| Gross Margin | 81.31% |
| Operating Margin | 28.64% |
| Pretax Margin | 28.15% |
| Profit Margin | 23.51% |
| EBITDA Margin | 41.63% |
| EBIT Margin | 28.64% |
| FCF Margin | n/a |
Dividends & Yields
LLY pays an annual dividend of $6, which amounts to a dividend yield of 0.69%.
| Dividend Per Share | $6.00 |
| Dividend Yield | 0.69% |
| Dividend Growth (YoY) | 32.74% |
| Payout Ratio | 51.11% |
| Earnings Yield | 1.34% |
| FCF Yield | 0% |
Analyst Forecast
The average price target for LLY is $1000.5, which is 14.6% higher than the current price. The consensus rating is "Buy".
| Price Target | $1000.5 |
| Price Target Difference | 14.6% |
| Analyst Consensus | Buy |
| Analyst Count | 27 |
Stock Splits
The last stock split was on Oct 16, 1997. It was a forward split with a ratio of 2:1.
| Last Split Date | Oct 16, 1997 |
| Split Type | forward |
| Split Ratio | 2:1 |
Scores
| Altman Z-Score | 9.46 |
| Piotroski F-Score | 5 |